Tirschwell & Loewy’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$14.9M Sell
63,141
-2,192
-3% -$690K 2.04% 23
2018
Q4
$19.7M Sell
65,333
-1,350
-2% -$431K 2.98% 16
2018
Q3
$23.6M Sell
66,683
-4,674
-7% -$1.61M 2.94% 16
2018
Q2
$20.7M Sell
71,357
-870
-1% -$245K 2.75% 16
2018
Q1
$19.8M Sell
72,227
-1,390
-2% -$431K 2.72% 18
2017
Q4
$23.5M Sell
73,617
-1,187
-2% -$381K 3.31% 11
2017
Q3
$23.4M Buy
74,804
+100
+0.1% +$29.6K 3.54% 8
2017
Q2
$20.3M Sell
74,704
-1,876
-2% -$496K 3.18% 11
2017
Q1
$20.9M Sell
76,580
-675
-0.9% -$191K 3.39% 8
2016
Q4
$21.9M Sell
77,255
-4,655
-6% -$1.38M 3.92% 6
2016
Q3
$25.6M Sell
81,910
-2,550
-3% -$755K 4.26% 3
2016
Q2
$20.4M Sell
84,460
-3,995
-5% -$1.05M 3.57% 9
2016
Q1
$23M Sell
88,455
-4,854
-5% -$1.28M 4.03% 4
2015
Q4
$28.6M Sell
93,309
-6,977
-7% -$2M 5.04% 1
2015
Q3
$29.3M Sell
100,286
-835
-0.8% -$276K 5.51% 1
2015
Q2
$40.8M Buy
101,121
+1,772
+2% +$711K 6.9% 1
2015
Q1
$41.9M Sell
99,349
-8,040
-7% -$3.17M 6.99% 1
2014
Q4
$36.5M Sell
107,389
-4,900
-4% -$1.59M 5.89% 2
2014
Q3
$37.1M Sell
112,289
-8,881
-7% -$2.93M 6.21% 1
2014
Q2
$38.2M Buy
121,170
+1,313
+1% +$395K 6.19% 1
2014
Q1
$36.7M Sell
119,857
-8,973
-7% -$2.85M 6.3% 1
2013
Q4
$36M Buy
128,830
+1,136
+0.9% +$294K 6.26% 1
2013
Q3
$30.7M Buy
127,694
+219
+0.2% +$49K 5.96% 1
2013
Q2
$27.4M Buy
+127,475
New +$27.2M 5.85% 1

Other funds holding BIIB

Tirschwell & Loewy's BIIB Position: Q1 2019 in Review

Tirschwell & Loewy reduced its Biogen (BIIB) stake by 3.4% in Q1 2019, selling an estimated $690K and leaving 63,141 shares worth $14.9M. The position accounts for 2.04% of the portfolio, ranked #23.

Tirschwell & Loewy first reported a position in BIIB in Q2 2013 and has held it in 24 quarters since. The position peaked at $41.9M in Q1 2015. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Tirschwell & Loewy held 63,141 shares of Biogen worth $14.9M as of Q1 2019.
  • Tirschwell & Loewy sold 2,192 Biogen shares in Q1 2019, an estimated $690K.
  • Biogen made up 2.04% of Tirschwell & Loewy's portfolio in Q1 2019, its #23 holding.
  • Tirschwell & Loewy first reported a position in Biogen in Q2 2013 and has held it in 24 quarters since.
  • Tirschwell & Loewy's Biogen position peaked at $41.9M in Q1 2015.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.